Jupiter Topco LLC Invests $681.58 Million in Stryker Corporation $SYK

Jupiter Topco LLC acquired a new stake in Stryker Corporation (NYSE:SYK) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,164,836 shares of the medical technology company’s stock, valued at approximately $681,581,000. Jupiter Topco LLC owned 0.56% of Stryker at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Gables Capital Management Inc. bought a new stake in Stryker in the 2nd quarter valued at $25,000. Kilter Group LLC bought a new position in shares of Stryker during the 2nd quarter worth about $25,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the fourth quarter valued at about $26,000. Sankala Group LLC bought a new stake in shares of Stryker in the fourth quarter valued at about $26,000. Finally, Compass Financial Management LLC bought a new position in Stryker during the second quarter valued at about $27,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on SYK. BTIG Research reduced their price objective on Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research report on Friday, July 31st. Argus set a $370.00 price objective on Stryker in a research report on Thursday, July 9th. Sanford C. Bernstein set a $410.00 target price on Stryker in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Stryker in a research note on Friday, May 1st. Finally, Leerink Partners lowered their price target on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $386.28.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 300,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the transaction, the director owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. This trade represents a 11.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Debra King sold 826 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares of the company’s stock, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 355,370 shares of company stock valued at $119,447,201. 4.60% of the stock is currently owned by company insiders.

Stryker Stock Performance

Shares of NYSE:SYK opened at $331.06 on Wednesday. The stock has a market capitalization of $126.98 billion, a P/E ratio of 34.31, a P/E/G ratio of 2.09 and a beta of 0.76. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $396.86. The business has a 50-day moving average price of $327.80 and a two-hundred day moving average price of $331.95.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts predict that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio is currently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.